ArticleScientific reports2026
Quality, reliability, and engagement of COPD-related videos on Chinese short-form video platforms: a cross-sectional content analysis.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Short-form video platforms are increasingly used to obtain information about chronic obstructive pulmonary disease (COPD), but the quality and reliability of COPD-related content across Chinese platforms remain unclear. We evaluated 228 COPD-related videos from Douyin, Kwai, and Bilibili using the Journal of the American Medical Association (JAMA) benchmark criteria, Global Quality Scale, modified DISCERN (mDISCERN), and Patient Education Materials Assessment Tool. Video characteristics, creator identity, verification status, content theme, presentation format, and visible engagement metrics were also analyzed. Video quality differed significantly across platforms. Douyin showed the highest transparency, reliability, and overall quality scores. Kwai showed the highest visible engagement but had lower overall quality and actionability scores. Bilibili had the longest videos and the highest understandability scores. Organization verified accounts generally achieved higher quality scores than individual verified or unverified accounts, although this finding should be interpreted cautiously because of the small number of such accounts. Visible engagement metrics, including likes, comments, saves, and shares, were not significantly correlated with medical quality scores. Together, these findings suggest that visible popularity is a poor proxy for medical quality. COPD-related digital health communication may benefit from more accessible evidence-based content, clearer source identification, and closer oversight of high-risk therapeutic claims.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.